NORDEY PHARMACEUTICALS PRIVATE LIMITED
NORDEY PHARMACEUTICALS PRIVATE LIMITED is a GUJARAT based PRIVATE LIMITED company, Registered at dated 21-DEC-2022 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of NORDEY PHARMACEUTICALS PRIVATE LIMITED is U24294GJ2022PTC137651 and registration number is 137651.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies AHMEDABAD India. Authorized share capital of NORDEY PHARMACEUTICALS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
NORDEY PHARMACEUTICALS PRIVATE LIMITED has 2 directors SURENDRA SOLANKI, SUNITA SOLANKI,
The registered Email address of NORDEY PHARMACEUTICALS PRIVATE LIMITED is nordeypharma@gmail.com and its registered address is 14, PRAMUKH RESIDENCY STATION ROAD, KARAMSAD ANAND ANAND GJ 388325 IN GUJARAT GUJARAT india 388325.
The current status of NORDEY PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
NORDEY PHARMACEUTICALS PRIVATE LIMITED
AHMEDABAD
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24294GJ2022PTC137651
21-DEC-2022
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
388325
INDIA
14, PRAMUKH RESIDENCY STATION ROAD, KARAMSAD ANAND ANAND GJ 388325 IN
nordeypharma@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
06543088 | SURENDRA SOLANKI | Director | 21/12/2022 |
09833014 | SUNITA SOLANKI | Director | 21/12/2022 |
Details Updated by Companies
Quick Links
- All Registered company of GUJARAT
- Company Registered in GUJARAT
- All Registered company of ANAND in GUJARAT
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.